Literature DB >> 22271121

Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism.

Connie M Rhee1, Ishir Bhan, Erik K Alexander, Steven M Brunelli.   

Abstract

BACKGROUND: Sudden exposure to high iodide levels may cause thyroid dysfunction. Despite compelling biological plausibility and clinical implication, the association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism has not been rigorously studied.
METHODS: We performed a nested case-control study of patients treated between January 1, 1990, and June 30, 2010, who did not have preexisting hyperthyroidism or hypothyroidism. In parallel analyses, incident hyperthyroid or hypothyroid cases were defined by a change in thyrotropin level from normal (at baseline) to low or high (follow-up measurement). Euthyroid controls were selected using an incidence density sampling approach and were matched to cases on the basis of age, sex, race/ethnicity, estimated glomerular filtration rate, follow-up thyrotropin measurement date, and interval between baseline and the follow-up thyrotropin measurement date. Iodinated contrast media exposure was assessed using claims data for contrast-enhanced computed tomography or cardiac catheterization.
RESULTS: In total, 178 and 213 incident hyperthyroid and hypothyroid cases, respectively, were matched to 655 and 779 euthyroid controls, respectively. Iodinated contrast media exposure was associated with incident hyperthyroidism (odds ratio [OR], 1.98; 95% CI, 1.08-3.60), but a statistically significant association with incident hypothyroidism was not observed (OR, 1.58; 95% CI, 0.95-2.62). In prespecified secondary analysis, iodinated contrast media exposure was associated with incident overt hyperthyroidism (follow-up thyrotropin level ≤ 0.1 mIU/L; OR, 2.50; 95% CI, 1.06-5.93) and with incident overt hypothyroidism (follow-up thyrotropin level >10 mIU/L; OR, 3.05; 95% CI, 1.07-8.72).
CONCLUSION: Iodinated contrast media exposure is associated with subsequent development of incident hyperthyroidism and incident overt hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271121     DOI: 10.1001/archinternmed.2011.677

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  51 in total

1.  Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals.

Authors:  Xiaoxi Zeng; Gearoid M McMahon; Steven M Brunelli; David W Bates; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

2.  [Drug therapy in interventional radiology].

Authors:  M Sumkauskaite; M Bryant; N Kortes; U Stampfl; B Radeleff
Journal:  Radiologe       Date:  2015-06       Impact factor: 0.635

Review 3.  Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions.

Authors:  Ezekiel Maloney; Ramesh S Iyer; Grace S Phillips; Shina Menon; John J Lee; Michael J Callahan
Journal:  Pediatr Radiol       Date:  2019-03-29

4.  Iodinated contrast-induced thyrotoxicosis.

Authors:  Paul Dunne; Nisha Kaimal; John MacDonald; Akheel A Syed
Journal:  CMAJ       Date:  2012-11-12       Impact factor: 8.262

Review 5.  Iodine-induced thyroid dysfunction.

Authors:  Angela M Leung; Lewis E Braverman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-10       Impact factor: 3.243

6.  Thyrotoxicosis: an under-recognised aetiology.

Authors:  Anjalee Dave; Jason Ludlow; John Malaty
Journal:  BMJ Case Rep       Date:  2015-05-20

7.  Percutaneous Coronary Intervention for Chronic Total Occlusion versus Percutaneous Coronary Intervention for Non-Complex Coronary Lesions: Is There a Different Impact on Thyroid Function?

Authors:  Çağın Mustafa Üreyen; Kahraman Coşansu; Mustafa Gökhan Vural; Sait Emir Şahin; Mehmet Akif Çakar; Harun Kılıç; Mustafa Tarık Ağaç; Hüseyin Gündüz; Ramazan Akdemir; Ersan Tatlı
Journal:  Med Princ Pract       Date:  2019-09-20       Impact factor: 1.927

Review 8.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

9.  Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

Authors:  Andrew S Allegretti; Xavier Vela Parada; Nwamaka D Eneanya; Hannah Gilligan; Dihua Xu; Sophia Zhao; Jules L Dienstag; Raymond T Chung; Ravi I Thadhani
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-09       Impact factor: 8.237

10.  Preoperative statin use and postoperative acute kidney injury.

Authors:  Steven M Brunelli; Sushrut S Waikar; Brian T Bateman; Tara I Chang; Joyce Lii; Amit X Garg; Wolfgang C Winkelmayer; Niteesh K Choudhry
Journal:  Am J Med       Date:  2012-10-09       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.